Geisinger Health and Acadia Healthcare Co. have formed a joint venture to provide inpatient behavioral health services in central and northeastern Pennsylvania, the companies announced today.
The organizations will invest close to $80 million to build two free-standing facilities in Moosic and Danville with plans to start serving adult and pediatric patients beginning in 2022 and 2023, respectively, according to a news release. The Danville location will be close to three Geisinger hospitals. Geisinger will consolidate its inpatient behavioral health services from Geisinger Medical Center, Geisinger Bloomsburg Hospital and Geisinger Community Medical Center.
“This joint venture was a natural fit based on a shared commitment to identifying behavioral health needs in the community and partnering to bring world-class care close to home for everyone who needs it in central and northeastern Pennsylvania,” said Dr. Jaewon Ryu, Geisinger’s president and CEO, in a prepared statement.
Geisinger chose Acadia Healthcare, the nation’s largest stand-alone behavioral health company, as its partner based on their shared commitment to quality care, strong clinical outcomes, and successful track record of collaborating with numerous premier health systems, according to the press release.
Acadia operates a network of 227 behavioral healthcare facilities with approximately 9,900 beds in 40 states and Puerto Rico. Other providers that have partnered with Acadia include Henry Ford Health System in Detroit and Scripps Health in California.
“We look forward to collaborating with Geisinger to create these two state-of-the-art, patient-centered facilities that will provide hope and healing for those in need,” said Acadia CEO Debbie Osteen in the news release. “The increased bed availability and freestanding structures will enable us to care for more patients who require these critical services and help meet the growing need for inpatient behavioral healthcare in these communities.”
The organizations said that the services that will be provided will be at a level “previously not seen in central and northeastern Pennsylvania, especially for children and adolescents.”